Personen

Prof. Dr. med. Patrick Most

Sektionsleiter (Sektion Molekulare und Translationale Kardiologie)
Arbeitsgruppenleiter (AG Molekulare und translationale Kardiologie)

Head, Molecular and Translational Cardiology Division
W3-Professor for Molecular and Translational Cardiology


06221 56-8900
06221 56-7809

Forschung/ Section of Molecular and Translational Cardiology

Academic Career

1991 – 1998

Study of Medicine (Medical Colleges of the University of
Heidelberg and University of Lübeck)
 

1998 – 1999

Medical Internship, University Hospital Lübeck

1999

Full license to practice medicine (Approbation)

1999 – 2002

Resident, Department of Cardiology, Angiology and
Pulmonology, University Hospital Lübeck
 

2002

Medical doctorate degree/thesis defense (summa cum laude)

2002 – 2006

Resident, Department of Cardiology, Angiology and
Pulmonology, University Hospital Heidelberg

2003 – 2004

Post-doctorate  training,  Center  for  Translational  Medicine,

Thomas Jefferson University, Philadelphia, USA

2006 – 2010

Assistant  Professor  of  Medicine  and  faculty  member  and,
Medical   College   and   Department   of   Medicine,   Thomas
Jefferson University Hospital, Philadelphia, USA
 

2009

Board certification

seit 2010

W3-Professor  for  Molecular  and  Translational  Cardiology, Medical College and Heidelberg University Hospital, Heidelberg Germany

Adjunct Associate Professor of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, USA

Bioindustrial Career

2013 – 2014

Co-founder and Chief Executive Officer of the Biotech Startup
InoCard GmbH

2014 – 2017

Managing Director of uniQure GmbH Germany (successor to InoCard GmbH and German affiliation of uniQure NV, Amsterdam, Netherlands)

2015 – 2017

Member of the uniQure NV leadership team and Senior Vice
President Cardiovascular Therapeutic Area
 

seit 2019

Co-founder of the Biotech Startup AaviGen GmbH

Awards/Honors

2001

German Society of Cardiology (DGK), of the Oskar Lapp
Foundation Science Award

2001

Council on Basic Cardiovascular Sciences (BCVS) of the American Heart Association (AHA), Trainee Award

2002

Council  on  Basic  Cardiovascular  Sciences  (BCVS)  of  the American Heart Association (AHA), Early Carrer Development Award

 

2004

Young Investigator Award of the German Society for Internal Medicine (DGIM)
 

2004

Wilhelm P. Winterstein Science Award of the German Heart

2004

Foundation (Deutsche Herzstiftung) Basic Science Award of the German Society for the Prevention  and  Rehabilitation  of  Cardiovascular  Diseases (DGPR)
 

2004

Council on Basic Cardiovascular Sciences (BCVS) of the American Heart Association (AHA), Louis N. and Arnold M. Katz Price Finalist

2007

W.W. Smith Charitable Trust stipend award

2009

Innovation Award of BioRegion Germany Association

2010

ADUMED Science Award, ADUMED Foundation

2013

Investors’ Choice Award  of the  Health Axis Europe/BioRN
Excellence cluster competition

2015

German Society of Cardiology (DGK), Albert-Fränkel Award

Patents (approved)

  • Cardiac power failure treatment (WO2000/02453)
  • Therapeutic Window S100A1 (PCT/EP13/186913)
  • Muscle function enhancing peptide (PCT/EP10/002343)
  • Short peptides for enhancing muscle function (PCT/EP13/880705)
  • Tissue specific gene therapy treatment (WO2008/054713)